Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

Fetal Atrial Flutter & Supraventricular Tachycardia (FAST) Therapy Trial
Fetal Atrial Flutter & Supraventricular Tachycardia (FAST) Therapy Trial
Sponsor:The Canadian Institutes of Health Research
Enrolling:Female Patients Only
Age Range:Between 16 and 30 years old
IRB Number:AAAR7726
U.S. Government ID:NCT02624765
Contact: Stephanie Levasseur, MD: 212-305-2359 / sl2363@cumc.columbia.edu
Additional Study Information:

The purpose of the study is to clarify the best treatment for your babys condition by looking at how well the medicine worked to bring your babys heart rate back to normal and if you experienced any side-effects from the treatment. You are being asked to take part in a research study because your fetus has been diagnosed with a fast heart rate. Although supraventricular tachycardia (SVT), including atrial flutter (AF), are the most common causes of intended in-utero fetal therapy, none of the medication used to date has been evaluated for their effects on the mother and her baby in a randomized controlled clinical trial (RCT). In the absence of such evidence, there is no consensus for the optimal management. The Fetal Atrial Flutter and Supraventricular Tachycardia (FAST) Therapy Trial is a prospective multi-center trial that addresses this knowledge gap to guide future fetal atrial flutter & SVT therapy to the best of care.

Do You Qualify?
Are you pregnant?YesNo
Does your baby have a faster than normal heart rate?YesNo
Submit
Cancel
Investigator
Stephanie Levasseur, MD
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Stephanie Levasseur, MD
Email: sl2363@cumc.columbia.edu
Phone: 212-305-2359